Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3740084012 | Ethinylestradiol and norelgestromin only product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740085013 | Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740086014 | Ethinyl estradiol and norelgestromin only product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5561001000241114 | produit contenant seulement de l'éthinylestradiol et de la norelgestromine sous forme transdermique | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Has active ingredient | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Has active ingredient | Norelgestromin (substance) | true | Inferred relationship | Some | 2 | |
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Is a | Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Is a | Ethinylestradiol and norelgestromin only product | true | Inferred relationship | Some | ||
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Plays role | Contraceptive therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Is a | True | Ethinylestradiol and norelgestromin only product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR